Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01545596 · ClinicalTrials.gov registry record · NA
Will a Real Time Advisory for Double Low State Change Clinical Behavior and Impact Outcomes
A NA study of Ability to Influence Behavior and Information Systems, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 20,237
- Enrollment target
- 1
- Study location
NCT01545596: Completed NA study of Ability to Influence Behavior and Information Systems, sponsored by Icahn School of Medicine at Mount Sinai.
NCT01545596 is a NA study of Ability to Influence Behavior and Information Systems that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 20,237 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1342% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01545596, a NA study of Ability to Influence Behavior and Information Systems, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 20,237 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to use a decision-support system combined with an electronic anesthesia record to detect double low clinical conditions (Mean Arterial Pressure (MAP) \< 75 mmHg, and Bispectral Index (BIS) \< 45) and generate alerts suggesting hemodynamic support. Specifically, the project will test the hypothesis that providing Double Low alerts reduces 90-day mortality. Secondary outcomes will be the fraction of alerts that generate early clinician responses, subsequent changes in MAP and hospital length of stay.
Conditions Studied
Interventions
- BEHAVIORAL Notification Group
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,237 participants |
| Start Date | 2011-01 |
| Est. Completion | 2014-05 |
| Phase | NA |
What the finished NCT01545596 record still lists
NCT01545596 is an interventional study that assigns participants to a tested intervention. Its 20,237 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1342% higher).
The record links to 2 conditions, with Ability to Influence Behavior appearing as the primary indexed condition, and to 1 intervention - of which Notification Group is the first listed.
NCT01545596 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01545596 about?
NCT01545596 is a clinical study titled "Will a Real Time Advisory for Double Low State Change Clinical Behavior and Impact Outcomes". The objective of this study is to use a decision-support system combined with an electronic anesthesia record to detect double low clinical conditions (Mean Arterial Pressure (MAP) \< 75 mmHg, and Bispectral Index (BIS) \< 45) and generate alerts suggesting hemodynamic support. Specifically, the pro...
What is the current status of trial NCT01545596?
This trial is currently completed. It is a NA study. The enrollment target is 20,237 participants. The study started on 2011-01. Estimated completion is 2014-05.
What conditions does trial NCT01545596 study?
This clinical trial studies the following conditions: Ability to Influence Behavior, Information Systems.
What interventions are being tested in trial NCT01545596?
The interventions under investigation include: Notification Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT01545596?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01545596 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01545596's enrollment target sits among peer trials
20,237 11th of 2000 higher than 1,990 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06062342 · 20,400 participants · NA
Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- NCT00900471 · 20,000 participants
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia